Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo-Reference-Cited by-同舟云学术

Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo

Published:1995-01 Issue:1 Volume:13 Page:57-62
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metast

Author:

Mohanam Sanjeeva,Wu Wang Shang,Rayford Alan,Yamamoto Masaaki,Sawaya Raymond,Nakajima Motowo,Liotta Lance A.,Nicolson Garth L.,Stetler-Stevenson William G.,Rao Jasti S.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00144019.pdf

Reference34 articles.

1. Matrisian LM, 1992, The matrix-degrading metalloproteinases. Bioessays, 14, 455?63.

2. Woessner JF, 1991, Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J, 5, 2145?54.

3. Stetler-Stevenson WG, Krutzsch HC and Liotta LA, 1989, Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family. J Biol Chem, 264, 17374?8.

4. Goldberg GI, Marmer BL, Grant GA, et al. 1989, Human 72-kDa type IV collagenase forms a complex with tissue inhibitor of metalloproteinase designated TIMP-2. Proc Natl Acad Sci USA, 86, 8207?11.

5. Goldberg GI, Strongin A, Collier IE, Genrich LT and Marmer BL, 1992, Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinase prevents dimerization, complex formation with interstitial collagenase and activation of the proenzyme with stromelysin. J Biol Chem, 267, 4583?91.

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contribution of Tissue Inhibitor of Metalloproteinase-2 Genotypes to Breast Cancer Risk in Taiwan;Life;2023-12-20

2. Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer;Diagnostics;2020-07-31

3. Role of MMP-2, MMP-9 and VEGF as serum biomarker in early prognosis of renal cell carcinoma;African Journal of Urology;2018-12

4. Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon, and prostate;Biochemistry and Cell Biology;2017-06

5. Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling;Scientific Reports;2016-03-04